- Conditions
- Charcot-Marie-Tooth Disease
- Interventions
- (RS)-baclofen, naltrexone hydrochloride and D-sorbitol, Placebo
- Drug
- Lead sponsor
- Pharnext S.C.A.
- Other
- Eligibility
- 16 Years to 65 Years
- Enrollment
- 350 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 20
- States / cities
- Los Angeles, California • Sacramento, California • New Britain, Connecticut + 16 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Charcot-Marie-Tooth Disease Type 1A
- Interventions
- PXT3003 dose 1, PXT3003 dose 2, placebo
- Drug
- Lead sponsor
- Pharnext S.C.A.
- Other
- Eligibility
- 16 Years to 65 Years
- Enrollment
- 323 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 11
- States / cities
- Los Angeles, California • New Britain, Connecticut • Gainesville, Florida + 8 more
- Conditions
- Charcot-Marie-Tooth Disease, Type IA
- Interventions
- PXT3003
- Drug
- Lead sponsor
- Pharnext S.C.A.
- Other
- Eligibility
- 17 Years to 67 Years
- Enrollment
- 187 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2024
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Gainesville, Florida • Kansas City, Kansas + 6 more